Comparison of presentation features between treatment arm
. | Treatment arm . | . | . | . | |
---|---|---|---|---|---|
. | ABCM, no. (%) . | CVAMP/HDM, no. (%) . | Total, no. . | P . | |
Total | 101 | 121 | 222 | ||
Sex | |||||
M | 52 (52) | 62 (51) | 114 | ||
F | 49 (48) | 59 (49) | 108 | .51 | |
Age, y | |||||
31-40 | 7 (7) | 1 (1) | 8 | ||
41-50 | 25 (24) | 27 (22) | 52 | ||
51-60 | 50 (50) | 68 (56) | 118 | ||
61-66 | 19 (19) | 25 (21) | 44 | .09 | |
B2M level, mg/L | |||||
Below 4 | 45 (45) | 52 (43) | 97 | ||
4-8 | 30 (29) | 37 (31) | 67 | ||
More than 8 | 22 (22) | 28 (23) | 50 | ||
Unknown | 4 | 4 | 8 | .93 | |
Hemoglobin level, g/L | |||||
Below 800 | 1300 (13) | 1300 (11) | 2600 | ||
800-1000 | 2700 (26) | 3600 (30) | 6300 | ||
More than 1000 | 5900 (59) | 65 (54) | 12 400 | ||
Unknown | 200 | 700 | 900 | .75 | |
Creatinine level, μM | |||||
Below 100 | 43 (43) | 57 (47) | 100 | ||
100-200 | 44 (43) | 49 (40) | 93 | ||
More than 200 | 14 (14) | 15 (13) | 29 | .83 |
. | Treatment arm . | . | . | . | |
---|---|---|---|---|---|
. | ABCM, no. (%) . | CVAMP/HDM, no. (%) . | Total, no. . | P . | |
Total | 101 | 121 | 222 | ||
Sex | |||||
M | 52 (52) | 62 (51) | 114 | ||
F | 49 (48) | 59 (49) | 108 | .51 | |
Age, y | |||||
31-40 | 7 (7) | 1 (1) | 8 | ||
41-50 | 25 (24) | 27 (22) | 52 | ||
51-60 | 50 (50) | 68 (56) | 118 | ||
61-66 | 19 (19) | 25 (21) | 44 | .09 | |
B2M level, mg/L | |||||
Below 4 | 45 (45) | 52 (43) | 97 | ||
4-8 | 30 (29) | 37 (31) | 67 | ||
More than 8 | 22 (22) | 28 (23) | 50 | ||
Unknown | 4 | 4 | 8 | .93 | |
Hemoglobin level, g/L | |||||
Below 800 | 1300 (13) | 1300 (11) | 2600 | ||
800-1000 | 2700 (26) | 3600 (30) | 6300 | ||
More than 1000 | 5900 (59) | 65 (54) | 12 400 | ||
Unknown | 200 | 700 | 900 | .75 | |
Creatinine level, μM | |||||
Below 100 | 43 (43) | 57 (47) | 100 | ||
100-200 | 44 (43) | 49 (40) | 93 | ||
More than 200 | 14 (14) | 15 (13) | 29 | .83 |
P values are associated with Pearson chi-square statistic. B2M indicates β2-microglobulin.